Velanne Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-65,701
Closed -$10.6M 9
2021
Q3
$10.6M Sell
65,701
-47,308
-42% -$8.07M 5.5% 10
2021
Q2
$18.6M Buy
113,009
+52,141
+86% +$8.63M 6.45% 5
2021
Q1
$10M Buy
60,868
+11,883
+24% +$1.92M 5.59% 8
2020
Q4
$7.71M Buy
48,985
+30,059
+159% +$4.44M 4.57% 12
2020
Q3
$2.82M Buy
18,926
+10,744
+131% +$1.59M 2.09% 17
2020
Q2
$1.15M Sell
8,182
-242
-3% -$35.3K 0.88% 20
2020
Q1
$1.1M Buy
8,424
+801
+11% +$114K 1.01% 21
2019
Q4
$1.11M Buy
+7,623
New +$1.03M 0.66% 23

Other funds holding JNJ

Velanne Asset Management's JNJ Position: Q4 2021 in Review

Velanne Asset Management sold out of Johnson & Johnson (JNJ) in Q4 2021, closing a stake of 65,701 shares — an estimated $10.6M sold.

Velanne Asset Management first reported a position in JNJ in Q4 2019 and held it in 8 quarters. The position peaked at $18.6M in Q2 2021. 3,644 funds tracked by Wall St. Rank hold JNJ as of Q4 2021.

  • Velanne Asset Management reported no remaining Johnson & Johnson position as of Q4 2021 after selling out during the quarter.
  • Velanne Asset Management sold 65,701 Johnson & Johnson shares in Q4 2021, an estimated $10.6M.
  • Velanne Asset Management first reported a position in Johnson & Johnson in Q4 2019 and held it in 8 quarters.
  • Velanne Asset Management's Johnson & Johnson position peaked at $18.6M in Q2 2021.
  • 3,644 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2021.

Based on Velanne Asset Management's 13F filing for Q4 2021.